Circulating tumor cells use the surface protein ICAM1 to strengthen stem cell programs and facilitate formation of tumor cell clusters, which can travel from primary tumors to other organs in the body.
Senior medical students and residents joined together to learn about and practice advanced physical diagnosis skills during a recent workshop on September 15.
Hypertension that leads to vascular dementia in older adults begins to impact the brain by middle age, according to a new study, the first to show the process beginning so early.
Northwestern Medicine physician-scientist Amy Heimberger, MD, has been named by President Biden to the National Cancer Advisory Board, which plays an important role in setting the course for the nation’s cancer research programs.
An international team of investigators have released the first-ever study to examine total energy expenditure over the course of the human lifespan, shedding light on human development and aging.
Epigenetic aging could serve as a promising biomarker for measuring long-term cardiovascular health and disease risk, according to a recent Northwestern Medicine study.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has been awarded a five-year, $9.2 million grant renewal from the National Cancer Institute to continue a Specialized Program of Research Excellence (SPORE) in prostate cancer.
Priscilla Ambrosi, a student in Northwestern University’s Interdepartmental Neuroscience (NUIN) PhD program, investigates midbrain dopamine circuits and how they control the automation of motor programs.
Women with early, nonviable pregnancies of unknown location who were given an active management strategy had more successful pregnancy resolutions than those given an expectant management strategy, according to a randomized clinical trial published in JAMA.
Northwestern Medicine scientists have developed an antibody that they believe can be used to treat muscular dystrophy, reducing muscle scarring in an animal model of the disease.